The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Biological Drugs Market Research Report 2024

Global Biological Drugs Market Research Report 2024

Publishing Date : Feb, 2024

License Type :
 

Report Code : 1908520

No of Pages : 96

Synopsis
The international biological drugs market is envisaged to grow at a handsome rate in the next few years. However, it could face challenges in the form of various product parameters, strict regulatory pathways and manufacturing processes, and longer product approvals, although biological drugs have historically shown better approval rates than conventional ones. Additionally, small players could find it difficult to enter the market because of the requirement of high capital expenditure.
The global Biological Drugs market was valued at US$ 283730 million in 2023 and is anticipated to reach US$ 508960 million by 2030, witnessing a CAGR of 8.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biological Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Drugs.
Report Scope
The Biological Drugs market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biological Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biological Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Myers Squibb
Eli Lilly
Takeda
Pfizer
Amgen
F. Hoffmann-La Roche
Johnson & Johnson
Merck
Abbott Laboratories
Baxter
Novartis
Biogen
GlaxoSmithKline
Segment by Type
Therapeutic Protein
Monoclonal Antibody
Vaccine
Others
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biological Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biological Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Biological Drugs Market Overview
1.1 Product Overview and Scope of Biological Drugs
1.2 Biological Drugs Segment by Type
1.2.1 Global Biological Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Therapeutic Protein
1.2.3 Monoclonal Antibody
1.2.4 Vaccine
1.2.5 Others
1.3 Biological Drugs Segment by Application
1.3.1 Global Biological Drugs Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Global Biological Drugs Market Size Estimates and Forecasts
1.4.1 Global Biological Drugs Revenue 2019-2030
1.4.2 Global Biological Drugs Sales 2019-2030
1.4.3 Global Biological Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Biological Drugs Market Competition by Manufacturers
2.1 Global Biological Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Biological Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Biological Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Biological Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biological Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biological Drugs, Product Type & Application
2.7 Biological Drugs Market Competitive Situation and Trends
2.7.1 Biological Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Biological Drugs Players Market Share by Revenue
2.7.3 Global Biological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biological Drugs Retrospective Market Scenario by Region
3.1 Global Biological Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Biological Drugs Global Biological Drugs Sales by Region: 2019-2030
3.2.1 Global Biological Drugs Sales by Region: 2019-2024
3.2.2 Global Biological Drugs Sales by Region: 2025-2030
3.3 Global Biological Drugs Global Biological Drugs Revenue by Region: 2019-2030
3.3.1 Global Biological Drugs Revenue by Region: 2019-2024
3.3.2 Global Biological Drugs Revenue by Region: 2025-2030
3.4 North America Biological Drugs Market Facts & Figures by Country
3.4.1 North America Biological Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Biological Drugs Sales by Country (2019-2030)
3.4.3 North America Biological Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Biological Drugs Market Facts & Figures by Country
3.5.1 Europe Biological Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Biological Drugs Sales by Country (2019-2030)
3.5.3 Europe Biological Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biological Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Biological Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Biological Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Biological Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Biological Drugs Market Facts & Figures by Country
3.7.1 Latin America Biological Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Biological Drugs Sales by Country (2019-2030)
3.7.3 Latin America Biological Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biological Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Biological Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Biological Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Biological Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Biological Drugs Sales by Type (2019-2030)
4.1.1 Global Biological Drugs Sales by Type (2019-2024)
4.1.2 Global Biological Drugs Sales by Type (2025-2030)
4.1.3 Global Biological Drugs Sales Market Share by Type (2019-2030)
4.2 Global Biological Drugs Revenue by Type (2019-2030)
4.2.1 Global Biological Drugs Revenue by Type (2019-2024)
4.2.2 Global Biological Drugs Revenue by Type (2025-2030)
4.2.3 Global Biological Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Biological Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Biological Drugs Sales by Application (2019-2030)
5.1.1 Global Biological Drugs Sales by Application (2019-2024)
5.1.2 Global Biological Drugs Sales by Application (2025-2030)
5.1.3 Global Biological Drugs Sales Market Share by Application (2019-2030)
5.2 Global Biological Drugs Revenue by Application (2019-2030)
5.2.1 Global Biological Drugs Revenue by Application (2019-2024)
5.2.2 Global Biological Drugs Revenue by Application (2025-2030)
5.2.3 Global Biological Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Biological Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bristol-Myers Squibb
6.1.1 Bristol-Myers Squibb Corporation Information
6.1.2 Bristol-Myers Squibb Description and Business Overview
6.1.3 Bristol-Myers Squibb Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bristol-Myers Squibb Biological Drugs Product Portfolio
6.1.5 Bristol-Myers Squibb Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Corporation Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eli Lilly Biological Drugs Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Takeda
6.3.1 Takeda Corporation Information
6.3.2 Takeda Description and Business Overview
6.3.3 Takeda Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Takeda Biological Drugs Product Portfolio
6.3.5 Takeda Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Biological Drugs Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Amgen
6.5.1 Amgen Corporation Information
6.5.2 Amgen Description and Business Overview
6.5.3 Amgen Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Amgen Biological Drugs Product Portfolio
6.5.5 Amgen Recent Developments/Updates
6.6 F. Hoffmann-La Roche
6.6.1 F. Hoffmann-La Roche Corporation Information
6.6.2 F. Hoffmann-La Roche Description and Business Overview
6.6.3 F. Hoffmann-La Roche Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 F. Hoffmann-La Roche Biological Drugs Product Portfolio
6.6.5 F. Hoffmann-La Roche Recent Developments/Updates
6.7 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson Biological Drugs Product Portfolio
6.7.5 Johnson & Johnson Recent Developments/Updates
6.8 Merck
6.8.1 Merck Corporation Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Merck Biological Drugs Product Portfolio
6.8.5 Merck Recent Developments/Updates
6.9 Abbott Laboratories
6.9.1 Abbott Laboratories Corporation Information
6.9.2 Abbott Laboratories Description and Business Overview
6.9.3 Abbott Laboratories Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Abbott Laboratories Biological Drugs Product Portfolio
6.9.5 Abbott Laboratories Recent Developments/Updates
6.10 Baxter
6.10.1 Baxter Corporation Information
6.10.2 Baxter Description and Business Overview
6.10.3 Baxter Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Baxter Biological Drugs Product Portfolio
6.10.5 Baxter Recent Developments/Updates
6.11 Novartis
6.11.1 Novartis Corporation Information
6.11.2 Novartis Biological Drugs Description and Business Overview
6.11.3 Novartis Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Novartis Biological Drugs Product Portfolio
6.11.5 Novartis Recent Developments/Updates
6.12 Biogen
6.12.1 Biogen Corporation Information
6.12.2 Biogen Biological Drugs Description and Business Overview
6.12.3 Biogen Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Biogen Biological Drugs Product Portfolio
6.12.5 Biogen Recent Developments/Updates
6.13 GlaxoSmithKline
6.13.1 GlaxoSmithKline Corporation Information
6.13.2 GlaxoSmithKline Biological Drugs Description and Business Overview
6.13.3 GlaxoSmithKline Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 GlaxoSmithKline Biological Drugs Product Portfolio
6.13.5 GlaxoSmithKline Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biological Drugs Industry Chain Analysis
7.2 Biological Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biological Drugs Production Mode & Process
7.4 Biological Drugs Sales and Marketing
7.4.1 Biological Drugs Sales Channels
7.4.2 Biological Drugs Distributors
7.5 Biological Drugs Customers
8 Biological Drugs Market Dynamics
8.1 Biological Drugs Industry Trends
8.2 Biological Drugs Market Drivers
8.3 Biological Drugs Market Challenges
8.4 Biological Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’